Professional saliva screening Saliva drug screening tests Fast, non-invasive solutions adapted to...
Laboratoire Toda Pharma
Expédition 24h
DPD ou Chronopost selon éligibilité
Fabricant français
Tests rapides certifiés CE
Qualité médicale
Environnement ISO 13485
+5 000 commandes expédiées
Confidentialité assurée
Écoutez notre épisode explicatif pour mieux interpréter les délais selon la substance, le type de test et le contexte.
The Drugdiag® 11 drugs urine test, developed by the French laboratory Toda Pharma, the leader in rapid diagnostic tests, allows simultaneous detection of 11 drug families in urine.
It notably detects THC-COOH, amphetamines, barbiturates, benzodiazepines, buprenorphine, cocaine, MDMA, methamphetamines, opiates, methadone, and tricyclic antidepressants.
This multi-drug test is particularly suited for businesses, occupational physicians, addiction treatment centers, health professionals, and organizations that need to secure environments with high levels of responsibility.
The Drugdiag® 11 urine test allows broad screening of the main families of psychoactive substances, including both the most common narcotics, certain psychoactive medications, and molecules used in addiction monitoring.
Thresholds must be interpreted according to the manufacturer’s instructions, clinical or professional context, and screening objectives. In case of a positive result, laboratory confirmation may be necessary depending on the context.
The Drugdiag® 11 is particularly suited for security and safety positions: transport, logistics, construction, heavy industry, maintenance of sensitive installations, energy, classified sites, or high-responsibility environments.
Thanks to the detection of methadone, buprenorphine, and TCA, this test can be useful for CSAPA, doctors, psychiatrists, clinics, and detox centers to document follow-up, complementing clinical interviews.
When provided for in internal regulations, this test can be integrated into an internal prevention procedure: targeted control, risk situation, accident, incident, or overall safety approach.
The Drugdiag® 11 can also be used by individuals for self-monitoring before a medical appointment, professional visit, or administrative procedure. Laboratory confirmation remains necessary in any official context.
In the workplace, the use of screening tests must be provided for in the internal regulations, justified by the nature of the tasks, and implemented in compliance with the Labor Code, employee rights, and confidentiality.
The Drugdiag® 11 test is part of a comprehensive prevention policy and never replaces clinical evaluation or confirmatory laboratory analyses when required.
The detection time of substances in urine depends on many factors: frequency of use, quantity, metabolism, health status, kidney function, hydration, ongoing treatment, and length of use.
These detection windows are indicative and can never serve as absolute proof of consumption or abstinence. They must be interpreted according to the clinical context, the person’s statements, and, if necessary, additional examinations.
A negative result indicates that the targeted drug families were not detected above the test thresholds. This does not guarantee the absolute absence of any substance.
A positive result indicates a reaction compatible with the presence of one or more targeted drug families in the urine. Laboratory confirmation is recommended in any official, medical, disciplinary, or disputed context.
An invalid result may be due to incorrect handling, insufficient sample volume, or failure to respect the reading time. In this case, the test should be repeated with a new device.
The device uses competitive immunochromatography with colloidal gold-labeled antibodies, allowing clear, rapid reading suitable for professional use.
The accuracy of this professional urine screening device has been compared to the laboratory reference method, gas chromatography coupled with mass spectrometry (GC/MS).
Designed by the French laboratory Toda Pharma, this in vitro diagnostic medical device is CE marked, complies with the ISO 13485 quality standard, and offers full batch traceability.
The test must be used according to the manufacturer's instructions. In case of a positive, doubtful, or disputed result, confirmation by laboratory analysis is still recommended.
It detects 11 families of substances in urine: THC-COOH, AMP, BAR, BZO, BUP, COC, MDMA, MET, MOP, MTD, and TCA.
It is intended for companies, occupational physicians, addiction centers, healthcare professionals, organizations exposed to security risks, and individuals wishing to perform responsible self-monitoring.
Yes. The BUP, MTD, and TCA panels, combined with other targeted families, can be useful in certain therapeutic or addiction follow-ups, complementing clinical evaluation.
Yes, if its use is provided for by internal regulations, justified by the nature of the tasks, proportionate to the risk, and implemented in compliance with the Labor Code, employee rights, and confidentiality.
No. A rapid test provides a preliminary analytical result. In any official, judicial, administrative, disciplinary, medical, or disputed context, confirmation by laboratory analytical method is recommended.
Need advice or a quote for a professional order?
Request a quote
Une solution fiable, rapide et simple à intégrer dans une démarche de prévention, adaptée aux conducteurs, entreprises, forces de l’ordre, professionnels de santé et particuliers.
Contrôlez votre état avant une visite médicale, une récupération de permis ou avant de reprendre le volant.
Renforcez la sécurité des équipes avec des outils adaptés aux postes à risques et aux procédures internes.
Utilisez un matériel professionnel éprouvé pour les missions de contrôle, de prévention et d’intervention terrain.
Levez le doute simplement, favorisez le dialogue et adoptez une démarche responsable d’auto-contrôle.
Développé par un laboratoire français, ce dispositif s’inscrit dans une démarche de prévention documentée, avec des exigences de qualité, de traçabilité et de fiabilité adaptées aux usages professionnels.
Toda Pharma, a French manufacturer of drug screening tests, was one of the first European laboratories to develop a rapid serological test for coronavirus detection as early as February 2020 and was validated by the National Reference Center (CNR), the Pasteur Institute, and the French Ministry of Solidarity and Health.
A study was conducted in 3 hospitals by different operators on 3 separate batches of each drug at concentrations of 0ng/ml, +/- 25%, and +/- 50% of the detection threshold for the drug in question. All results met expectations. The detailed tables of all results are available to users upon request.
Used by the French army for its screening tests, ensuring maximum accuracy and reliability.
The UAF label certifies that this test meets the highest standards, validated by the French armed forces. It offers a guarantee of quality and performance, providing screening as reliable as the tests used in military institutions.
The CE certification guarantees that our products meet the essential safety, health, and environmental protection requirements set by the European Union. It certifies that our breathalyzers and drug screening tests comply with European standards, ensuring safe and reliable use. By choosing a CE certified product, you can be confident that it has been rigorously tested and meets the quality and safety standards in force on the European market.
The ISO 13485 standard is an international benchmark that certifies the quality of medical devices. This certification confirms that our manufacturing processes comply with the highest standards of quality and risk management. Our screening tests are designed and produced under strict conditions to ensure their reliability, safety, and effectiveness. By choosing our ISO 13485 certified products, you can be confident that you are using equipment that meets the medical sector’s requirements, delivering accurate and consistent results.
Toda Pharma is honored to receive the "Cœur Alsace" label, a symbol of excellence and commitment to our region. This prestigious label recognizes our dedication to high-quality, innovative local production that respects the strictest standards. Based in Strasbourg, Toda Pharma embodies Alsatian expertise in the service of health and public safety.
